Availability of anti-tuberculosis drugs in Europe.
نویسندگان
چکیده
Acknowledgements: The members of the SMIRA Group were: C. Piersimoni (Ospedali Riuniti, Ancona, Italy); P. Lorenzetti (Ospedale di Aosta, Aosta, Italy); D. Costa (Policlinico di Bari, Bari, Italy); A. Grimaldi (Ospedale Fallacara, Triggiano, Bari, Italy); M. Arosio and A. Goglio (Ospedali Riuniti, Bergamo, Italy); C. Mazza and L. Squintani (Ospedale Maggiore, Bologna, Italy); C. Larcher and E. Frizzera (Azienda Sanitaria dell’Alto Adige, Bolzano, Italy); G. Pinsi (Spedali Civili, Brescia, Italy); R. Caddeu and A.G. Farris (Ospedale Binaghi, Cagliari, Italy); C. Di Naso (Policlinico Ospedaliero Garibaldi Centro, Catania, Italy); P. Cavalcanti (Ospedale Annunziata, Cosenza, Italy); G. Tomei and G. Mantini (Ospedale di Chieti, Chieti, Italy); E. Tortoli and M. T. Simonetti (Azienda Ospedaliera-Universitaria di Careggi, Florence, Italy); A. di Taranto (Ospedale di Foggia, Foggia, Italy); E. Senno (Ospedale S. Martino, Genoa, Italy); S. Nisticò (Ospedale di Lamezia Terme, Catanzaro, Italy); C. Colonna and L. Buono (Ospedale Contrada Ambulante, Matera, Italy); E. Mazzola and G. Gesu (Azienda Ospedaliera Niguarda Ca Granda, Milan, Italy); P. Cichero (Ospedale S. Raffaele, Milan); A. Lombardi (Ospedale L. Sacco, Milan); A. Fabio, (Policlinico di Modena, Modena, Italy); G. Santoro (Azienda Ospedaliera dei Colli, Ospedale V. Monaldi, Naples, Italy); G.L. Molinari and A. Camaggi (Azienda OspedalieroUniversitaria Maggiore della Carità, Novara, Italy); M.G. Chirillo (Azienda Ospedaliero-Universitaria S. Luigi Gonzaga, Orbassano, Turin, Italy); M. Peracchi and L. Fallico (Azienda OspedalieraUniversità di Padova, Padua, Italy); P. Marone and L. Bono (IRCCS S. Matteo, Pavia, Italy); R. Mazzolla and C. Tiecco (Azienda Ospedaliera S. Maria della Misericordia, Perugia, Italy); P. Chiaradonna, M. Tronci and A. M. Altieri (Azienda Ospedaliera S. Camillo-Forlanini, Rome, Italy); E. Bordi, P. De Mori and A. Di Caro (INMI, Ospedale L. Spallanzani, Rome); E. Libanori and S. De Lorenzo (Azienda Ospedaliera Valtellina e Valchiavenna, Sondalo, Italy); R. Milano and A. Mondo (Ospedale A. Di Savoia, Turin); A. Barbui (Azienda Ospedaliero-Universitaria S. Giovanni Battista, Turin); R. Centis, L. D’Ambrosio and A. Spanevello (Fondazione S. Maugeri, Tradate, Italy); I. Caola (Ospedale di Trento, Trent, Italy); C. Fabris (Azienda OspedalieroUniversitaria, Ospedali Riuniti, Trieste, Italy); and M.C. Screm and C. Scarparo (Azienda Ospedaliero-Universitaria S. Maria della Misericordia, Udine, Italy).
منابع مشابه
Availability, price and affordability of anti-tuberculosis drugs in Europe: a TBNET survey.
Data on availability and cost of anti-tuberculosis (TB) drugs in relation to affordability at national level are scarce. We performed a cross-sectional study on availability and cost of anti-TB drugs at major TB-reference centres in 37 European countries. Costs of standardised treatment regimens used for pan-sensitive TB, multidrug-resistant (MDR) TB, pre-extensively drug-resistant (XDR) TB, an...
متن کاملSTUDY ON THE HEPATOTOXICITY OF ANTI-TUBERCULOSIS DRUGS IN 190 PATIE NTS WITH PULMONARY AND E XTRAPULMONARY TUBERCULOSIS
Tuberculosis is one of the oldest diseases that affects humans. The cause of this disease is Mycobacterium tuberculosis. This disease affects approximately 8.8 million people worldwide and led to over 3 million deaths in 1995. 95% of those affected and 98% of deaths occurred in developing countries. Hepatic reactions constitute a major proportion of drug reactions to antituberculosis drugs ...
متن کاملبررسی عوارض داروهای ضد سل در مبتلایان HIV
Background: Tuberculosis with high prevalence in HIV/AIDS patients is the main reason for morbidity and mortality in these patients. About one-third of patients with HIV infection have concomitant tuberculosis. Lack of appropriate infection control on many social and economic communities will impose. Comprehensive study on the effects of anti-tuberculosis drugs in patients with HIV infecti...
متن کاملAnti-Mycobacterium Tuberculosis Effects of Folk Medicinal Plants in Iran: A Mini-Systematic Review
The emergence of drug resistance in Mycobacterium tuberculosis is a major challenge in tuberculosis treatment and control. In addition, multidrug resistance (MDR) and, more broadly, extensive drug resistance (XDR) have hampered treatment with common antibiotics. Thus, an herbal medicine containing antimicrobial capability can be a good alternative to antituberculosis drugs. In this study, we re...
متن کاملTuberculosis in Immigrants to Cartagena de Indias, Colombia
Introduction: Tuberculosis (TB) affects vulnerable populations. Immigrants have contributed to the increased incidence of TB. In this population, TB has some common characteristics that can lead to increased resistance to anti-TB drugs and undesired outcomes. In Cartagena de Indias, Colombia, an increase in TB cases has been observed in immigrants. Our objective is to describe ...
متن کاملبررسی درمان کوتاه مدت سل در بخش کودکان بیمارستان امام خمینی (ره)، 71-1367
Tuberculosis appears to be a disease as old as human history. Tuberculosis is of great public health importance in the developing countries. Its clinical profile is different in developing countries in comparison to countries of Europe and North America. The recent epidemic of HIV has slowed down the declining trend in the incidence of tuberculosis. Bacilli are transmitted from one infected per...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- The European respiratory journal
دوره 40 2 شماره
صفحات -
تاریخ انتشار 2012